MedTrace Logo

Impact of Congenital Heart Disease on Neurodevelopmental Outcome

NCT03871881 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-05-10

No results posted yet for this study

Summary

The project aims toward clarifying the underlying mechanism and the long-term impact of congenital heart disease on neurodevelopment.

Conditions

  • Heart Defects, Congenital

Interventions

OTHER

Magnetic Resonance Imaging

Magnetic Resonance Imaging (MRI) of the brain's macro- and microstructures. Furthermore, brain regional interactions and activity is examined with quantitative functional-MRI (fMRI)

OTHER

Neuropsychological assessment

A special designed neuropsychological test battery of validated tests to assess function of cognitive domains

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Vibeke Hjortdal, MD, PhD · University of Aarhus

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2023-08-01
Completion
2023-08-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03871881 on ClinicalTrials.gov